Infection of human T lymphocytes with varicella-zoster virus: An analysis with viral mutants and clinical isolates

Journal of Virology

Volumn 74, Issue 4, 2000, Pages 1864-1870

  Soong, Weily ^a   Schultz, Julie C ^a   Patera, Andriani C ^a   Sommer, Marvin H ^b   Cohen, Jeffrey I ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ARTICLE; CHICKENPOX; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; MONONUCLEAR CELL; OPEN READING FRAME; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL CORD BLOOD; VARICELLA ZOSTER VIRUS; VIRUS ISOLATION; VIRUS MUTANT; VIRUS REPLICATION;

CELLS, CULTURED; CHICKENPOX; COCULTURE TECHNIQUES; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; LEUKOCYTES, MONONUCLEAR; MUTATION; PROTEIN KINASES; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; VIRAL VACCINES;

EID: 0033934283     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.4.1864-1870.2000     Document Type: Article

References (21)

1. Andiman, W. A. 1989. Epstein Barr virus, p. 407-452. In N. J. Schmidt and R. W. Emmons (ed.). Diagnostic procedures for viral, rickettsial, and chlamydial infections. American Public Health Association, Washington, D.C.
2. Arvin, A., J. F. Moffal, and R. Redman. 1996. Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. Adv. Virus Res. 46:263-309.
3. Asano, Y., N. Itakura, Y. Hiroshi, S. Hirose, T. Osaki, T. Yazaki, K. Yamanishi, and M. Takahashi. 1985. Viremia is present in incubation period in nonimmunocompromised children with varicella. J. Pediatr. 106:69-71.
4. Asano, Y., N. Itakura, Y. Kajita, S. Suga, T. Yoshikawa, T. Yazaki, T. Ozaki, K. Yamanishi, and M. Takahashi. 1990. Severity of viremia and clinical findings in children with varicella. J. Infect. Dis. 161:1095-1098.
5. Black, J. B., K. C. Sanderlin, C. S. Goldsmith, H. E. Gary, C. Lopez, and P. E. Pellett. 1989. Growth properties of human herpesvirus-6 strain Z29. J. Virol. Methods 26:133-146.
6. Cohen, J. I., and K. E. Seidel. 1993. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc. Natl. Acad. Sci. USA 90:7376-7380.
7. Cohen, J. I., and K. E. Seidel. 1995. Varicella-zoster virus open reading frame 1 encodes a membrane protein that is dispensable for growth of VZV in vitro. Virology 206:835-842.
8. Cohen, J. I., and S. E. Straus. 1996. Varicella-zoster virus and its replication, p. 2525-2545. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology. Lippincott-Raven Publishers, Philadelphia, Pa.
9. Cox, E., S. Reddy, I. Iofin, and J. I. Cohen. 1998. Varicella-zoster virus ORF57, unlike its pseudorabies virus UL3.5 homolog, is dispensable for viral replication in cell culture. Virology 250:205-209.
10. Hayakawa, Y., S. Torigoe, K. Shiraki, K. Yamanishi, and M. Takahashi. 1984. Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients. J. Infect. Dis. 149:956-963.
11. Heineman, T. C., and J. I. Cohen. 1995. The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22. J. Virol. 69:7367-7370.
12. Heineman, T. C., K. E. Seidel, and J. I. Cohen. 1996. The varicella-zoster virus ORF66 protein induces kinase activity and is dispensable for viral replication. J. Virol. 70:7312-7317.
13. Koropchak, C. M., G. Graham, J. Palmer, M. Winsberg, S. F. Ting, M. Wallace, C. G. Prober, and A. M. Arvin. 1991. Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella. J. Infect. Dis. 163:1016-1022.
14. Koropchak, C. M., S. M. Solem, P. S. Diaz, and A. M. Arvin. 1989. Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization. J. Virol. 63:2392-2395.
15. Mainka, C., B. Fub, H. Geiger, H. Hofelmayr, and M. H. Wolf. 1998. Characterization of viremia at different stages of varicella-zoster virus infection. J. Med. Virol. 56:91-98.
16. Moffat, J. F., L. Zerboni, M. H. Sommer, T. C. Heineman, J. I. Cohen, H. Kaneshima, and A. M. Arvin. 1998. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc. Natl. Acad. Sci. USA 95:11969-11974.
17. Moffat, J. F., L. Zerboni, P. R. Kinchington, C. Grose, H. Kaneshima, and A. M. Arvin. 1998. Attenuation of vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 72:965-974.
18. + T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69:5236-5242.
19. Ozaki, T., T. Ichikawa, Y. Matsui, H. Kondo, T. Nagai, Y. Asano, K. Yamanishi, and M. Takahashi. 1986. Lymphocyte-associated viremia in varicella. J. Med. Virol. 19:249-253.
20. Reddy, S. M., E. Cox, I. Iofin, W. Soong, and J. I. Cohen. 1998. Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase. J. Virol. 72:8083-8088.
21. Sawyer, M. H., Y. N. Wu, C. J. Chamberlin, C. Burgos, S. K. Brodine, W. A. Bowler, A. LaRocca, E. O. Oldfield, and M. R. Wallace. 1992. Detection of varicella-zoster virus DNA in oropharynx and blood of patients with varicella. J. Infect. Dis. 166:885-888.